Should Altria Stock Be Part of Your Portfolio Post Q4 Earnings?

Core Insights - Altria Group, Inc. demonstrated resilience in its fourth-quarter 2025 performance, maintaining earnings growth despite ongoing cigarette volume declines and regulatory challenges [1][9] - The company has effectively utilized pricing power, disciplined cost management, and strategic investments in smoke-free alternatives to protect margins [1][21] Stock Performance - Following the fourth-quarter results released on January 29, 2026, Altria's shares increased by 12%, indicating improved investor confidence in its earnings stability [2] - Over the past three months, Altria's shares rose by 15.9%, outperforming the Zacks Consumer Staples sector's 12.1% and the S&P 500's 3.7% [3] - Compared to peers, Altria's performance was solid, with notable gains from Turning Point Brands (31.9%), Philip Morris (21.8%), and British American Tobacco (11.3%) [4] Financial Results - Altria's fourth-quarter adjusted earnings remained flat year-over-year at $1.30, with net revenues declining by 2.1% to $5.8 billion, primarily due to lower revenues in the smokeable products segment [9][10] - Domestic cigarette shipment volumes fell by 7.9% in the quarter, contributing to revenue pressures, but adjusted operating companies income (OCI) remained resilient at $2.64 billion with margins at 60.4% [11] - The Oral Tobacco Products segment also contributed positively, with adjusted OCI declining slightly to $440 million but showing growth in the modern oral portfolio [12] Capital Returns - Altria paid $7 billion in dividends in 2025, including $1.8 billion in the fourth quarter, showcasing strong cash generation capabilities [13] - The company repurchased 4.8 million shares for $288 million in the fourth quarter, with a total of 17.1 million shares repurchased for approximately $1 billion in the full year [14] 2026 Outlook - Management expects 2026 adjusted EPS in the range of $5.56 to $5.72, indicating growth of 2.5% to 5.5% from 2025 [15] - The outlook is based on anticipated pricing strength, cost discipline, and planned investments in smoke-free products, with capital expenditures projected between $300 million and $375 million [16] Valuation - Altria is currently trading at a forward P/E ratio of 11.98X, significantly lower than the industry average of 16.07X and the S&P 500's average of 22.9X, making it attractive for value-focused investors [17] - Compared to peers, Altria's valuation is appealing, as Philip Morris and Turning Point Brands trade at higher multiples of 22.39X and 31.65X, respectively [18] Investor Sentiment - The post-earnings rally reflects growing recognition of Altria's consistent execution, resilient margins, and dependable cash-return framework [21] - Despite ongoing structural challenges, the company's ability to offset pressures through pricing and cost management enhances its appeal for long-term, income-oriented investors [21]